On 29 January, The Guardian ran a story on a Swedish study, which found that artificial intelligence (AI)-supported ...

The oncolytic virus therapy landscape has expanded steadily over the past decade, with over 100 companies worldwide pursuing clinical or preclinical programs. A few leaders, such as Candel ...

Baystreet.ca News Commentary – The global oncology therapeutics market reached $164.2 billion in 2025 and is projected to hit $285.4 billion by 2030[1]; it signaled a massive ...

An updated edition of the December 17, 2025, article. The global oncology market is entering a phase of accelerated transformation, driven by rising cancer incidence, demographic shifts and rapid ...

An experimental drug combination was able to effectively treat pancreatic cancer in mouse models without tumor resistance.

A new four-marker blood test accurately detects pancreatic cancer, including early stages, raising hopes for earlier ...

The DURIPANC study evaluates Ampligen, an immune system modulator, in combination with Imfinzi, a PD-L1 immune checkpoint ...

Moving gemcitabine/nab-paclitaxel to every-other-week dosing decreases infusion visits and may lessen cumulative toxicity, ...

A new study reveals that cancer patients diagnosed during the early COVID-19 pandemic had worse short-term survival rates.

Under terms announced December, Cencora acquired shares in OneOncology from TPG and other shareholders for approximately $3.6 ...

The Institute of Cancer Research has welcomed Sutton Council’s approval of ambitious plans led by Aviva Capital Partners and Socius to create around one million square feet of new life-sciences ...

Researchers at The Institute of Cancer Research, London, have uncovered how the DNA repair enzyme XPF-ERCC1 is recruited to sites of damage and activated inside cells, resolving a long-standing ...